erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Abnormalities, Drug-Induced D000014 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abscess D000038 13 associated lipids
Peritonsillar Abscess D000039 1 associated lipids
Acne Vulgaris D000152 35 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Actinomycosis, Cervicofacial D000197 1 associated lipids
Adenocarcinoma D000230 166 associated lipids
Agammaglobulinemia D000361 4 associated lipids
Airway Obstruction D000402 13 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Anemia, Hemolytic, Autoimmune D000744 5 associated lipids
Anemia, Hypochromic D000747 5 associated lipids
Angiomatosis D000798 1 associated lipids
Animal Diseases D000820 2 associated lipids
Aortic Aneurysm D001014 8 associated lipids
Aortic Valve Stenosis D001024 4 associated lipids
Spider Bites D001098 1 associated lipids
Arthritis D001168 41 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
DikiÄ­ BN [Sensitivity of different Proteus species to antibiotics]. 1971 Antibiotiki pmid:4945575
KORCHAGIN VB et al. [APROPOS OF THE SPECTROPHOTOMETRIC DETERMINATION OF ERYTHROMYCIN]. 1964 Antibiotiki pmid:14341270
SokolovskiÄ­ VT and Genchikov LA [Use of antibiotics in surgery]. 1971 Antibiotiki pmid:4945579
Bilibin AF et al. [Clinical study of erythromycin ascorbate for parenteral use]. 1967 Antibiotiki pmid:4869727
SamoÄ­lovich NN [Sensitivity to antibiotics of pyogenic Staphylococci isolated from hospitalized and ambulatory patients]. 1967 Antibiotiki pmid:5595923
Agarunova IuS and Suteeva TG [On the sensitivity of pathogenic aerobic-Actinomyces to antibiotics and sulfanilamides]. 1966 Antibiotiki pmid:4871095
Kuznetsova SM [Erythromycin in the modern antibiotic therapy of bacterial infections (a review lecture)]. 1982 Antibiotiki pmid:7103441
Finn GR et al. [Graphic analytical evaluation of the effectiveness of methods for the quantitative determination of the combined action of antibiotics]. 1973 Antibiotiki pmid:4360240
Bass TM [Effect of ecmoline on the resistance of staphylococci to antibiotics]. 1973 Antibiotiki pmid:4491920
KLIMOVA NE [STIMULATING EFFECT OF ERYTHROMYCIN ON THE DEVELOPMENT OF CHICK EMBRYO]. 1965 Antibiotiki pmid:14294740
Vasil'eva NG and Poliak MS [Microflora of sputum in pneumonias and its sensitivity to antibiotics]. 1967 Antibiotiki pmid:4386255
Red'ko AF [Dynamics of the change of the composition of microflora and its sensitivity toward antibiotics in purulent inflammatory processes of lungs]. 1966 Antibiotiki pmid:4385185
Zak AF and Batuashvili TA [Component composition and admixtures of related compounds in commercial preparations with an erythromycin base]. 1977 Antibiotiki pmid:596843
Lopatin AI [Erythromycin in the treatment of non-gonorrheal urethritis in males]. 1965 Antibiotiki pmid:5887636
Bartoshevich Iu et al. [Utilization of automatic systems for determining the biological activity of antibiotics by the agar diffusion method]. 1976 Antibiotiki pmid:1275462
Govorovich EA et al. [Macrolide antibiotics for oral intake in the treatment and prevention of suppurative surgical infection]. 1976 Antibiotiki pmid:1275486
Lazareva EN et al. [Erythromycin-ascorbinate--a drug for parenteral administration]. 1966 Antibiotiki pmid:5973448
MartinevskiÄ­ IL et al. [Trial use of polymyxin and erythromycin for isolating cultures of the plague microbe in the Kyzyl-Kum]. 1982 Antibiotiki pmid:6295257
Shorin VA and Shapovalova SP [The antibacterial and chemotherapeutic activity of the Soviet produced antibiotic rifamitsina SV]. 1974 Antibiotiki pmid:4156904
Levina AA [Biological properties of staphylococci and the sensitivity to antibiotics of the flora isolated from patients with chronic purulent otitis media]. 1969 Antibiotiki pmid:4998534
Krotkova MR [Effect of antibiotics and preparations with stimulatory effect on the phagocytic and cytochemical properties of macrophages in tissue culture]. 1971 Antibiotiki pmid:5131436
GOLIKOV AV [CONCENTRATION OF SOME ANTIBIOTICS IN ACTINOMYCOMA AND IN THE BLOOD OF ANIMALS WITH ACTINOMYCOSIS]. 1963 Antibiotiki pmid:14160060
GAMALEIA LA [Experimental study on combinations of tetracycline with oleandomycin, erythromycin and novobiocin]. 1963 Antibiotiki pmid:13946308
Kuzin MI et al. [Efficacy of kanamycin in surgical infection. (Experimental-clinical study)]. 1967 Antibiotiki pmid:4969447
Smolianskaia AZ and Grinenko GI [Dissemination of bacteria with multiple drug resistance in patients in the Oncological Clinic]. 1967 Antibiotiki pmid:4970184
Ermol'eva EV [Antibiotic preparations and their role in the sharp decline of infection]. 1967 Antibiotiki pmid:4970635
AFONINA LG and NEMIROVSKAIA BM [Experience with the use of intramuscular tetracycline injections and erythromycin tablets in the treatment of complicated influenza in children]. 1961 Antibiotiki pmid:13859534
VeÄ­s RA and Storozhev IA [Experimental study of erythromycin phosphate]. 1969 Antibiotiki pmid:5768791
Dushkin VA et al. [How to obtain specific pathogen-free mice by the antibiotic decontamination method]. 1971 Antibiotiki pmid:4333291
Ganin VS et al. [Comparative in vitro study of antibiotic resistance increase in classical cholera and E1 Tor vibrios]. 1971 Antibiotiki pmid:4333292
Turushev VA [Distribution of antibiotic resistance of enteric microblora in cattle on farms of the Amur and Chita region]. 1971 Antibiotiki pmid:4333294
Solov'ev VN and Shilova SV [Mathematical model for the control and standardization of discs]. 1975 Antibiotiki pmid:1225183
L'in'kovà OS and Zhukovskaia SA [Effect of the degree of dilution of the antibiotic fermentation broths on the filtration indices]. 1975 Antibiotiki pmid:1225211
Velizhenko GG [Effect of thiamine, riboflavin and ascorbic acid on tetracycline, erythromycin and levomycetin activity]. 1975 Antibiotiki pmid:1225212
Liashenko IuI [Erythromycin and oleandomycin concentration in the body of angina patients taking the preparations orally]. 1975 Antibiotiki pmid:1229996
Buniatova IM and Kotua EN [Study of transplacental passage of erythromycin ascorbinate]. 1971 Antibiotiki pmid:5553280
MOROZ AF and SHIBAEVA IV [ACQUIRED BACTERIAL RESISTANCE TO ANTIBIOTICS FROM THE ERYTHROMYCIN GROUP]. 1963 Antibiotiki pmid:14076094
BAIKINA VM et al. [STUDIES ON THE TYPICAL COMPOSITION OF ERYTHROMYCIN PRODUCED BY STRAIN NO. 2577 OF ACT. ERYTHREUS]. 1963 Antibiotiki pmid:14076097
Kostareva MG et al. [Comparative evaluation of different solvents for erythromycin]. 1971 Antibiotiki pmid:5557387
TRISHKINA ET [Experimental studies on erythromycin and on its effectiveness in erysipeals]. 1962 Antibiotiki pmid:13922521
Pavlov EP and Koniaev GA [Effect of rifampicin on transference of drug resistance factors in Staphylococcus aureus]. 1973 Antibiotiki pmid:4685116
Ustiuzhanina IIu et al. [Purification of antibiotics by ultrafiltration through semi-permeable membranes]. 1983 Antibiotiki pmid:6418062
Vepkhvadze LK [Sensitivity to antibiotics and phage typing of pathogenic staphylococci isolated from patients and medical personnel]. 1966 Antibiotiki pmid:4226609
Vaysblat AS et al. [Treatment of trachoma and epidemic conjunctivitis with ditetracycline]. 1966 Antibiotiki pmid:4226610
LAZAREVA EN et al. [Water-soluble erythromycin salts]. 1962 Antibiotiki pmid:14463086
Kharchenko GI [The action of antibiotics on the electrokinetic properties of blood serum proteins]. 1966 Antibiotiki pmid:4291643
Griaznova NS et al. [Effect of lincomycin and other protein synthesis inhibitors on the metabolism of Actinomyces roseolus, a producer of lincomycin]. 1980 Antibiotiki pmid:7369728
Klimov AN et al. [Effect of mitomycin C, actinomycin C and some other antibiotics on the transformation of streptococci]. 1966 Antibiotiki pmid:4172492
Stolpnik VG et al. [Study of the mode of the action of the antibiotic neotelomycin and formation of bacteria resistant to it]. 1966 Antibiotiki pmid:4172969
POLIAK MS [ERYTHROMYCIN IN THE TREATMENT OF ACUTE INFLAMATORY DISEASES OF THE BILIARY TRACT]. 1964 Antibiotiki pmid:14239572
Khashim AM and Kharitonovaam [Study of the action of erythromycin on the function of thyroid gland]. 1966 Antibiotiki pmid:4174546
Bolkhovitinova LA et al. [Antibiotics in the treatment of burns]. 1968 Antibiotiki pmid:4175285
ZAKARIAN LM [ON MODIFIED ANTIBIOTIC SENSITIVITY OF STAPHYLOCOCCI CULTIVATED WITH CANDIDA ALBICANS]. 1964 Antibiotiki pmid:14242807
Minkova GL [On the sensitivity of microflora of burn wounds to antibiotics]. 1968 Antibiotiki pmid:4305269
Gitinov GG and Lunacharskaia TV [Gastric microbial flora and its sensitivity to antibiotics following a short-time use of the tetracyclines morphocycline and glycocycline]. 1970 Antibiotiki pmid:4395425
Baskanchiladze GSh and Buniatova IM [Change in the sensitivity to antibiotics of pathogenic staphylococci, isolated in Tiflis during 1961-1966]. 1968 Antibiotiki pmid:4303353
IAKOBSON LM et al. [Attempted international standardization of erythromycin]. 1958 Mar-Apr Antibiotiki (Mosc) pmid:24544839
Calvert H et al. Effect of erlotinib on CYP3A activity, evaluated in vitro and by dual probes in patients with cancer. 2014 Anticancer Drugs pmid:24637575
Ohkura K et al. Flexible structure of cytochrome P450: promiscuity of ligand binding in the CYP3A4 heme pocket. 2009 Anticancer Res. pmid:19414330
Kiso S et al. Inhibitory effect of erythromycin on P-glycoprotein-mediated biliary excretion of doxorubicin in rats. 2000 Sep-Oct Anticancer Res. pmid:11062690
Gunics G et al. Enhanced antibacterial effect of erythromycin in the presence of 3,5-dibenzoyl-1,4-dihydropyridines. 2001 Jan-Feb Anticancer Res. pmid:11299745
OSWALD EJ et al. IN VITRO ANTISTAPHYLOCOCCAL EFFECTS OF ERYTHROMYCIN COMBINED WITH SEMISYNTHETIC PENICILLINS. 1964 Antimicrob Agents Chemother (Bethesda) pmid:14287966
GUZE LB and KALMANSON GM EFFECT OF ERYTHROMYCIN ON IN VIVO "PROTOPLAST" INFECTION. 1964 Antimicrob Agents Chemother (Bethesda) pmid:14288026
Garrison DW et al. Comparison of in vitro antibacterial activities of 7-chloro-7-deoxylincomycin, lincomycin, and erythromycin. 1967 Antimicrob Agents Chemother (Bethesda) pmid:5596165
Duncan IB Development of lincomycin resistance by staphylococci. 1967 Antimicrob Agents Chemother (Bethesda) pmid:5596212
TAUBMAN SB et al. EFFECT OF ERYTHROMYCIN ON PROTEIN BIOSYNTHESIS IN BACILLUS SUBTILIS. 1963 Antimicrob Agents Chemother (Bethesda) pmid:14274930
SELL SH and SANDERS RS THERAPY WITH ERYTHROMYCIN ESTOLATE FOR OTITIS MEDIA ASSOCIATED WITH HAEMOPHILUS INFLUENZAE INFECTION. 1963 Antimicrob Agents Chemother (Bethesda) pmid:14274999
MOFFETT HL et al. ERYTHROMYCIN ESTOLATE AND PHENOXYMETHYL PENICILLIN IN THE TREATMENT OF STREPTOCOCCAL PHARYNGITIS. 1963 Antimicrob Agents Chemother (Bethesda) pmid:14275000
Spizek J et al. Biogenetic relationship of the erythromycins and the lactone of erythromycin B. 1965 Antimicrob Agents Chemother (Bethesda) pmid:5883418
Grady JE and Stern KF Penetration of lincomycin into bone. 1965 Antimicrob Agents Chemother (Bethesda) pmid:5883427
Rasch JR and Mogabgab WJ Therapeutic effect of erythromycin on Mycoplasma pneumoniae pneumonia. 1965 Antimicrob Agents Chemother (Bethesda) pmid:5883484
Whaley HA et al. LL-A0341 A and B, new antibiotics. I. Isolation and characterization. 1966 Antimicrob Agents Chemother (Bethesda) pmid:5985292
Wilhelm JM et al. Interaction of antibiotics with ribosomes: structure-function relationships and a possible common mechanism for the antibacterial action of the macrolides and lincomycin. 1967 Antimicrob Agents Chemother (Bethesda) pmid:4970204
Perun TJ et al. Conformation of mactolide antibiotics. IV. Nuclear magnetic resonance, circular dichroism, and chemical studies of erythromycin derivatives. 1969 Antimicrob Agents Chemother (Bethesda) pmid:5396476
Jones PH et al. Chemical modifications of erythromycin antibiotics. II. Synthesis of 4'-hydroxyerythromycin A. 1969 Antimicrob Agents Chemother (Bethesda) pmid:5396478
Zinner SH et al. Erythromycin plus alkalinization in treatment of urinary infections. 1969 Antimicrob Agents Chemother (Bethesda) pmid:5396518
Weinstein MJ et al. Preliminary studies on megalomicin, a new Micromonospora-produced macrolide antibiotic complex. 1968 Antimicrob Agents Chemother (Bethesda) pmid:5735370
Paterson PY and Madden GM Occurrence and erythromycin susceptibility of penicillin-resistant Viridans streptococci in rheumatic fever patients on oral penicillin prophylaxis. 1968 Antimicrob Agents Chemother (Bethesda) pmid:5735376
McGehee RF R et al. Resistance of Staphylococcus aureus to lincomycin, clinimycin, and erythromycin. 1968 Antimicrob Agents Chemother (Bethesda) pmid:5735385
Wick WE and Mallett GE New analysis for the therapeutic efficacy opropionyl erythromycin and erythromycin base. 1968 Antimicrob Agents Chemother (Bethesda) pmid:5735386
Kawamata J and Nakajima K Mode of action of colistin. 1965 Antimicrob Agents Chemother (Bethesda) pmid:5327517
Boyd RJ and Godzeski CW Selected antibiotic effects on the L-phase of Protus mirabilis in tissue culture. 1970 Antimicrob Agents Chemother (Bethesda) pmid:5521355
Dhamdhere G et al. Interplay between drug efflux and antioxidants in Escherichia coli resistance to antibiotics. 2010 Antimicrob. Agents Chemother. pmid:20876376
Reig M et al. Resistance of Peptostreptococcus spp. to macrolides and lincosamides: inducible and constitutive phenotypes. 1992 Antimicrob. Agents Chemother. pmid:1622181
Retsema J et al. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. 1987 Antimicrob. Agents Chemother. pmid:2449865
Perronne C et al. Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages. 1990 Antimicrob. Agents Chemother. pmid:2171421
Spigaglia P et al. ErmB determinants and Tn916-Like elements in clinical isolates of Clostridium difficile. 2005 Antimicrob. Agents Chemother. pmid:15917571
Haas CE et al. In vitro selection of resistant Helicobacter pylori. 1990 Antimicrob. Agents Chemother. pmid:2285275
Braga PC et al. Flow cytometric assessment of susceptibilities of Streptococcus pyogenes to erythromycin and rokitamycin. 2003 Antimicrob. Agents Chemother. pmid:12499226
DiPersio LP et al. Prevalence of the erm(T) gene in clinical isolates of erythromycin-resistant group D Streptococcus and Enterococcus. 2008 Antimicrob. Agents Chemother. pmid:18285483
Bourne CR et al. Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1. 2010 Antimicrob. Agents Chemother. pmid:20606069
Yasuda Y et al. Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model. 2007 Antimicrob. Agents Chemother. pmid:17353244
Yajko DM et al. Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome. 1987 Antimicrob. Agents Chemother. pmid:3501698
Koomanachai P et al. Pharmacodynamic profile of tigecycline against methicillin-resistant Staphylococcus aureus in an experimental pneumonia model. 2009 Antimicrob. Agents Chemother. pmid:19738006
Shaila MS et al. Protein synthesis in Mycobacterium tuberculosis H37Rv and the effect of streptomycin in streptomycin-susceptible and -resistant strains. 1973 Antimicrob. Agents Chemother. pmid:4202339
Goodman CD et al. Chemobiosynthesis of new antimalarial macrolides. 2013 Antimicrob. Agents Chemother. pmid:23208707
Griffith RS et al. Synergistic action of erythromycin and cefamandole against Bacteroides fragilis subsp. fragilis. 1977 Antimicrob. Agents Chemother. pmid:879736
Portillo A et al. Macrolide resistance genes in Enterococcus spp. 2000 Antimicrob. Agents Chemother. pmid:10722498
Le Saux NM et al. In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi. 1987 Antimicrob. Agents Chemother. pmid:2959199
Conte JE et al. Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin. 2004 Antimicrob. Agents Chemother. pmid:15328118